17 Patents
- US125826682026Methods for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
Arrowhead Pharmaceuticals, Inc.
0 cites - US125515692026Rnai Agents for Inhibiting Expression of Microtubule Associated Protein Tau (MAPT), Compositions Thereof, and Methods of Use
Arrowhead Pharmaceuticals, Inc.
0 cites - US125036962025Rnai Agents for Inhibiting Expression of Inhibin Subunit Beta E (INHBE), Pharmaceutical Compositions Thereof, and Methods of Use
Arrowhead Pharmaceuticals, Inc.
0 cites - 0 cites
- US124420022025Rnai Agents for Inhibiting Expression of Activin Receptor-like Kinase 7 (ALK7), Compositions Thereof, and Methods of Use
Arrowhead Pharmaceuticals, Inc.
0 cites - US123785582025Rnai Agents for Inhibiting Expression of Complement Factor B (CFB), Pharmaceutical Compositions Thereof, and Methods of Use
Arrowhead Pharmaceuticals, Inc.
0 cites - US123658992025Rnai Agents and Compositions for Inhibiting Expression of Apolipoprotein C-III (APOC3)
Arrowhead Pharmaceuticals, Inc.
0 cites - 0 cites
- 0 cites
- US121104922024Rnai Agents for Inhibiting Expression of Complement Component C3 (C3), Pharmaceutical Compositions Thereof, and Methods of Use
Arrowhead Pharmaceuticals, Inc.
0 cites - US120547182024Rnai Agents for Inhibiting Expression of PNPLA3, Pharmaceutical Compositions Thereof, and Methods of Use
Arrowhead Pharmaceuticals, Inc.
0 cites - US119129972024Rnai Agents for Inhibiting Expression of Superoxide Dismutase 1 (SOD1), Compositions Thereof, and Methods of Use
Arrowhead Pharmaceuticals, Inc.
0 cites - US118849202024Alpha-1 Antitrypsin (AAT) Rnai Agents, Compositions Including AAT Rnai Agents, and Methods of Use
Arrowhead Pharmaceuticals, Inc.
0 cites - US118459372023Rnai Agents for Inhibiting Expression of DUX4, Compositions Thereof, and Methods of Use
Arrowhead Pharmaceuticals, Inc.
0 cites - US116293492023Rnai Agents for Inhibiting Expression of Xanthine Dehydrogenase (XDH), Pharmaceutical Compositions Thereof, and Methods of Use
ARROWHEAD PHARMACEUTICALS, Inc.
0 cites - 0 cites
- US115491122023Rnai Agents for Inhibiting Expression of Xanthine Dehydrogenase (XDH), Pharmaceutical Compositions Thereof, and Methods of Use
ARROWHEAD PHARMACEUTICALS, Inc.
0 cites